ReviewEuropean cardiology2015
Home Blood Pressure Monitoring.
Review in European cardiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
54 citing papers in PubMed, 2 syntheses or guidelines pooled it, 97 citations in OpenAlex.
- Wearable Blood Pressure Monitoring Devices: Understanding Heterogeneity in Design and Evaluation.IEEE transactions on bio-medical engineering · 2024Pooled it
- Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).European heart journal · 2020Guideline
- Feasibility of Decentralised Response-Guided Albuminuria Monitoring to Optimise Empagliflozin and Finerenone Therapy in Type 2 Diabetes and Chronic Kidney Disease.Diabetes, obesity & metabolism · 2026Trial
- Effectiveness of the Green Heart Smartphone Application as a Self-Management Intervention for Hypertension and Dyslipidemia: A Randomized Clinical Trial.Archives of Iranian medicine · 2024Trial
- Effectiveness of Aerobic, Resistance, and Combined Training for Hypertensive Patients: A Randomized Controlled Trial.Ethiopian journal of health sciences · 2023Trial
- Effects of Controlled Supramaximal High-Intensity Interval Training on Cardiorespiratory Fitness and Global Cognitive Function in Older Adults: The Umeå HIT Study-A Randomized Controlled Trial.The journals of gerontology. Series A, Biological sciences and medical sciences · 2023Trial
- Choice of home blood pressure monitoring device: the role of device characteristics among Alaska Native and American Indian peoples.BMC cardiovascular disorders · 2022Trial
- Effect of high nitrate vegetable juice supplementation on plasma nitrate and blood pressure in adults: a pilot randomized crossover intervention in healthy volunteers.Journal of nutritional science · 2022Trial
- Trial
- Remote and self-monitoring for pregnant women at risk of gestational hypertensive disorders: a cost-effectiveness analysis.The European journal of health economics : HEPAC : health economics in prevention and care · 2026Article
- Qualitative insights into the experiences and goals of people living with severe difficult-to-treat hypertension in Australia.BMC cardiovascular disorders · 2026Article
- Blood pressure status, JSH 2019-based control rate, and associated factors among community-dwelling adults: The NOSE study.Hypertension research : official journal of the Japanese Society of Hypertension · 2026Article
- First the relationship, then the technology: Healthcare professionals' perceptions on how digital health solutions impact the interaction with patients.PEC innovation · 2026Article
- The Role of Metabolomics in Understanding Hypertension: Protocol for a Systematic Review and Meta-Analysis.JMIR research protocols · 2026Article
- Correlation of Systolic and Diastolic Blood Pressure in Measuring Blood Pressure Using Validated Digital Wrist Monitor Versus Validated Digital Arm Monitor: Study in a Real-World Setting.International journal of hypertension · 2026Article
- Latent classification of time-dependent transition rates in longitudinal binary outcome data.Statistical methods in medical research · 2026Article
- Adherence to the European Society of Cardiology hypertension guidelines over 12 years of follow-up in the Irish population.Open heart · 2025Article
- From Innovation to Integration: Bridging the Gap Between IoMT Technologies and Real-World Health Management Systems.Sensors (Basel, Switzerland) · 2025Article
- Current status of the use of validated home blood pressure monitoring devices among Korean patients with hypertension.Hypertension research : official journal of the Japanese Society of Hypertension · 2025Article
- Cuffless Blood Pressure Monitor for Home and Hospital Use.Sensors (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertension is the most common preventable cause of cardiovascular disease. Home blood pressure monitoring (HBPM) is a self-monitoring tool that can be incorporated into the care for patients with hypertension and is recommended by major guidelines. A growing body of evidence supports the benefits of patient HBPM compared with office-based monitoring: these include improved control of BP, diagnosis of white-coat hypertension and prediction of cardiovascular risk. Furthermore, HBPM is cheaper and easier to perform than 24-hour ambulatory BP monitoring (ABPM). All HBPM devices require validation, however, as inaccurate readings have been found in a high proportion of monitors. New technology features a longer inflatable area within the cuff that wraps all the way round the arm, increasing the 'acceptable range' of placement and thus reducing the impact of cuff placement on reading accuracy, thereby overcoming the limitations of current devices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.